Search results
Results From The WOW.Com Content Network
A proportion of patients will require orthodox treatment, a proportion will do much better on orthomolecular treatment, and the rest will need a skillful blend of both." [ 38 ] Nevertheless, advocates have said that the right nutrients at the optimum dose for the individual concerned can prevent, [ 39 ] treat, and sometimes cure a wide range of ...
The Journal of Orthomolecular Medicine is not indexed by MEDLINE, a database of biomedical literature.Journals are selected for MEDLINE by the National Library of Medicine based on scope and coverage, quality of content, quality of editorial work, intended audience, quality of the layout, printing, graphics, and illustrations. [6]
[2] [3] Orthomolecular psychiatry's goal of weaning patients from conventional neuroleptic drugs [4] follows "Pfeiffer's Law", "For every drug that benefits a patient, there is a natural substance that can achieve the same effect". [5] In 1968, Linus Pauling first used the term orthomolecular. [6] [7]
The major shortcoming of most patient portals is their linkage to a single health organization. If a patient uses more than one organization for healthcare, the patient normally needs to log on to each organization's portal to access information. This results in a fragmented view of individual patient data.
3-Methylsalicylic acid is an organic compound with the formula CH 3 C 6 H 3 (CO 2 H)(OH). It is a white solid that is soluble in basic water and in polar organic solvents. At neutral pH, the acid exists as 3-methylsalicylate Its functional groups include a carboxylic acid and a phenol group.
ortho-Carborane is the organoboron compound with the formula C 2 B 10 H 12. The prefix ortho is derived from ortho. It is the most prominent carborane. This derivative has been considered for a wide range of applications from heat-resistant polymers to medical applications. It is a colorless solid that melts, without decomposition, at 320 °C
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. [3]On May 8, 2020 the U.S. Food and Drug Administration (FDA) issued to Quidel the first emergency use authorization (EUA) for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic.
Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions: Ortho-McNeil , based in Raritan, NJ (United States); the division is focused on primary care .